Is MRSN or RYLD a better dividend investment in 2026?

MRSN currently yields 6.88% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: RYLD offers higher current income.

What is the dividend yield difference between MRSN and RYLD?

MRSN has a forward dividend yield of 6.88% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 5.26 percentage points.

Home › Compare › MRSN vs RYLD

MRSN vs RYLD: Dividend Comparison 2026

MRSN yields 6.88% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RYLD wins by $13.0K in total portfolio value

INVESTMENT

TIME HORIZON10 years

MRSN

● Live price

6.88%

Share price

$29.08

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.5K

Annual income

$1,064.67

Full MRSN calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — MRSN vs RYLD

📍 RYLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MRSN	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MRSN + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MRSN pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MRSN

Annual income on $10K today (after 15% tax)

$584.59/yr

After 10yr DRIP, annual income (after tax)

$904.97/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, RYLD beats the other by $1,294.28/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MRSN + RYLD for your $10,000?

MRSN: 50%RYLD: 50%

100% RYLD50/50100% MRSN

Portfolio after 10yr

$38.0K

Annual income

$1,826.01/yr

Blended yield

4.80%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRSN right now

MRSN

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$10.00

-65.6% upside vs current

Range: $3.00 — $17.00

Altman Z

-23.2

Piotroski

2/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MRSN buys

RYLD buys

No recent congressional trades found for MRSN or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMRSNRYLD

Forward yield	6.88%	12.14% ✓
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$31.5K	$44.5K ✓
Annual income after 10y	$1,064.67	$2,587.35 ✓
Total dividends collected	$8.8K	$18.8K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: MRSN vs RYLD ($10,000, DRIP)

Year	MRSN Portfolio	MRSN Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$11,388	$687.76	$11,914	$1,213.65	$526.00 → RYLD
2	$12,917	$731.96	$14,099	$1,351.30	$1.2K → RYLD
3	$14,597	$775.93	$16,580	$1,494.55	$2.0K → RYLD
4	$16,438	$819.50	$19,384	$1,642.61	$2.9K → RYLD
5	$18,451	$862.49	$22,535	$1,794.70	$4.1K → RYLD
6	$20,648	$904.79	$26,063	$1,950.00	$5.4K → RYLD
7	$23,039	$946.25	$29,995	$2,107.69	$7.0K → RYLD
8	$25,639	$986.78	$34,361	$2,266.99	$8.7K → RYLD
9	$28,460	$1,026.28	$39,194	$2,427.12	$10.7K → RYLD
10	$31,517	$1,064.67	$44,525	$2,587.35	$13.0K → RYLD

MRSN vs RYLD: Complete Analysis 2026

MRSN — Stock

Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also develops XMT-1660, a B7-H4-targeted Dolasynthen ADC candidate; and XMT-2056, an immunosynthen development candidate. It has a strategic research and development partnerships with Merck KGaA and Asana BioSciences, LLC for the development of ADC product candidates utilizing Fleximer. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was incorporated in 2001 and is headquartered in Cambridge, Massachusetts.

Full MRSN Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this MRSN vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MRSN vs SCHD MRSN vs JEPI MRSN vs O MRSN vs KO MRSN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.